Pathophysiology of Allergic Rhinitis

International Archives of Allergy and Immunology

Volumn 110, Issue 3, 1996, Pages 207-218

  Bousquet, Jean ^a   Vignola, Antonio Maurizio ^a,b   Campbell, Alison M ^a   Michel, François Bernard ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b Istituto di Fisiopatologia Respiratoria   (Italy)

Author keywords

Allergy; Eosinophils; Mechanisms; Rhinitis

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; IMMUNOGLOBULIN E;

ALLERGIC RHINITIS; EOSINOPHIL; HUMAN; IMMUNOREACTIVITY; NOSE MUCOSA; NOSE SECRETION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW;

EID: 0029943175     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237289     Document Type: Article

References (165)

1. Pipkom U: Hay fever: In the laboratory and at natural allergen exposure, Allergy 1988;8:41 — 44.
2. Naclerio RM, Meier HI., Kagey-Sobotka A, Adkinson N Jr., Meyers DA, Norman PS, Lichtenstein LM: Mediator release after nasal airway challenge with allergen, Am Rev Respir Dis 1983:128:597-602.
3. Fokkens WJ, Vroom TM, Rijntjes E, Mulder PG: Fluctuation of the number of CD-1(T6)-positive dendritic cells, presumably Langer-hans cells, in the nasal mueosa of patients with an isolated grass-pollcn allergy before, during, and after the grass-pollen season, J Allergy Clin Immunol 1989;84:39-43.
4. Fokkens WJ, Godthelp T, Holm AF, Blom H, Mulder PG, Vroom TM, Rijntjes E: Dynamics of mast cells in the nasal mucosa of patients with allergic rhinitis and non-allcrgic controls: A biopsy study, Clin Exp Allergy 1992:22:701-710.
5. Gomez E, C’orrado OJ, Baldwin DL, Swanston AR, Davies RJ: Direct in vivo evidence for mast cell degranulation during allergen-induced reactions in man, J Allergy Clin Immunol 1986; 78:637-645.
6. Bentley AM, Jacobson MR, Cumberworth V, Barkans JR, Moqbel R, Schwartz LB, Irani AM, Kay AB, Durham SR: Immunohistology of the nasal mucosa in seasonal allergic rhinitis: Increases in activated eosinophils and epithelial mast cells, J Allergy Clin Immunol 1992:89: 877-883.
7. Igarashi Y, Kaliner MA, Hausfeld JN, Irani AA, Schwartz LB, White MV: Quantification of resident inflammatory cells in the human nasal mucosa, J Allergy Clin Immunol 1993:91: 1082-1093.
8. Holmberg K, Bake B, Pipkom U: Nasal mucosal blood flow after intranasal allergen challenge, J Allergy Clin Immunol 1988:81:541-547.
9. Hauser-Kronberger C, Hacker GW, Muss W, Saria A, Albegger K: Autonomic and peptidergic innervation of human nasal mucosa, Acta Otolaryngol (Stockh) 1993:113:387-393.
10. Okayama M, Mullol J, Baraniuk JN, Hausfcld JN, Feldman B, Merida M, Shelhamer JH, Kaliner MA: Muscarinic receptor subtypes in human nasal mucosa: Characterization, autoradiographic localization, and function in vitro, Am J Respir Cel I Mol Biol 1993:8:176-187.
11. Baraniuk JN, Lundgren JD, Okayama M, Mullol J, Merida M, Shelhamer JII, Kaliner MA: Vasoactive intestinal peptide in human nasal mucosa, J Clin Invest 1990:86:825-831.
12. Baraniuk JN, Lundgren JD, Mizoguchi H, Pc-den D, Gawin A, Merida M, Shelhamer JH, Kaliner MA: Bradykinin and respiratory mucous membranes, Analysis of bradykinin binding site distribution and secretory' responses in vitro and in vivo, Am Rev Respir Dis 1990:141:706-714.
13. Baraniuk JN, Castcllino S, Lundgren JD, Goff J, Mullol J, Merida M, Shelhamer JH, Kaliner MA: Neuropeptide Y (NPY) in human nasal mucosa, Am J Respir Cell Mol Biol 1990:3: 165-173.
14. Baraniuk JN, Lundgren JD, Goff J, Peden D, Merida M, Shelhamer J, Kaliner M: Gastrin-releasing peptide in human nasal mucosa, J Clin Invest 1990;85:998-1005.
15. Baraniuk JN, Lundgren JD, Goff J, Mullol J, Castcllino S, Merida M, Shelhamer JH, Kaliner MA: Calcitonin gene-related peptide in human nasal mucosa, Am J Physiol 1990:258:181-188.
16. Baraniuk JN, Ohkubo K, Kwon OJ, Mak J, Rohde J, Kaliner MA, Durham SR, Barnes PJ: Identification of neutral endopeptidase mRNA in human nasal mucosa, J Appl Physiol 1993; 74:272-279.
17. Lacroix JS, Anggard A, Hokfelt T, O'llare MM, Fahrenkrug J, Lundberg JM: Neuropeptide Y: Presence in sympathetic and parasympathetic innervation of the nasal mucosa, Cell Tissue Res 1990:259:119-128.
18. Baraniuk JN, Kaliner MA: Neuropeptides and nasal secretion, J Allergy Clin Immunol 1990; 86:620-627.
19. Anggard A: Basic mechanisms in autonomic nervous responses in specific and nonspecific nasal hyperreactivity, Acta Otolaryngol (Stockh) 1993:113:394-396.
20. Tani E, Shiosaka S, Sato M, Ishikawa T, Tohya-ma M: Histamine acts directly on calcitonin gene-related peptide- and substance P-contain-ing trigeminal ganglion neurons as assessed by calcium influx and immunocytochemistry, Ncurosci Lett 1990:115:171-176.
21. Tonnesen P, Schaffalitzky-dc-Muckadell OB: Substance P and vasoactive intestinal peptide in serotonin-induced nasal secretions in normal subjects, Allergy 1987:42:146-150.
22. Baraniuk JN, Lundgren JD, Okayama M, Goff J, Mullol J, Merida M, Shelhamer JH, Kalincr MA: Substance P and neurokinin A in human nasal mucosa, Am J RcspirCell Mol Biol 1991: 4:228-236.
23. Guamaccia S, Baraniuk JN, Bellanti J, Duina M: Calcitonin gene-related peptide nasal provocation in humans, Ann Allergy 1994:72:515-519.
24. Mullol J, Rieves RD, Baraniuk JN, Lundgren JD, Merida M, Hausfeld JH, Shelhamer JH, Ka-liner MA: The effects of neuropeptides on mucous glycoprotein secretion from human nasal mucosa in vitro, Neutopeptides 1992:21:231 -238.
25. Baraniuk JN, Silver PB, Lundgren JD, Cole P, Kaliner MA, Barnes PJ: Bombesin stimulates human nasal mucous and serous cell secretion in vivo, Am J Physiol 1992;262:L48-L52.
26. Baraniuk JN, Silver PB, Kaliner MA, Barnes PJ: Neuropeptide Y is a vasoconstrictor in human nasal mucosa, J Appl Physiol 1992:73: 1867-1872.
27. Brandtzaeg P: Immunocompetent cells of the upper airway: Functions in normal and diseased mucosa, Eur Arch Otorhinolaryngol SuppI 1995; 1 :S8—S21.
28. Yang PC, Okuda M, Pawakar R, Aihara K: Electron microscopical studies of the cell population in ansal secretions, Rhinology 1995:33:70—77.
29. Davidsson A, Karlsson MG, Hellquist LIB: Al-Icrgcn-induced changes of B-ccll phenotypes in patients with allergic rhinitis, Rhinology 1994; 32:184-190.
30. Lcbcl B, Bousquet J, Morel A, Chanal I, Godard P, Michel FB: Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains, J Allergy Clin Immunol 1988:82:869-877.
31. Friedman MM, Kalincr M: In situ degranulation of human nasal mucosal mast cells: Ultrastruc-tural features and cell-cell associations, J Allergy Clin Immunol 1985:76:70-82.
32. Miadonna A, Tcdcschi A, Leggicri E, Lorini M, Folco CI, Sala A, Qualizza R, Froldi M, Zanussi C: Behavior and clinical relevance of histamine and leukotricnes C4 and B4 in grass pollen-induced rhinitis, Am Rev Respir Dis 1987; 136: 357-362.
33. Creticos PS, Peters SP, Adkinson N Jr., Naclerio RM, Hayes EC, Norman PS, Lichtenstein LM: Peptide leukotriene release after antigen challenge in patients sensitive to ragweed, N Engl J Med 1984;310:1626-1630.
34. Volovitz B, Wclliver RC, De-Castro G, Krysto-fik DA, Ogra PL: The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: Role in obstructive airway disease, Pediatr Res 1988;24:504-507.
35. Meslier N, Braunstein G, Lacronique J, Dcs-sanges JF, Rakotosihanaka F, Devillier P, Lockhart A, Menica-Huerta JM, Boushey HA: Local cellular and humoral responses to antigenic and distilled water challcnce in subjects with allergic rhinitis, Am Rev Respir Dis 1988:137:617- 624.
36. Shaw RJ, Fitzharris P, Cromwell O, Wardlaw AJ, Kay AB: Allergen-induced release of sul-phidopeptide leukotricnes (SRS-A) and LTB4 in allergic rhinitis, Allergy 1985:40:1 —6.
37. Castells M, Schwartz LB: Tryptasc levels in na-sal-lavage fluid as an indicator of the immediate allergic response, J Allergy Clin Immunol 1988;82:348-355.
38. Juliusson S, Holmberg K, Baumgarten CR, Ols-son M, Enander I, Pipkom U: Tryptase in nasal lavage fluid after local allergen challenge, Relationship to histamine levels and TAM E-esterase activity, Allergy 1991;46:459-465.
39. Baroody FM, Ford S, Lichtenstein I.M, Kagey-Sobotka A, Naclerio RM: Physiologic responses and histamine release after nasal antigen challenge, Effect of atropine, Am J Respir Crit Care Med 1994:149:1457-1465.
40. Smith TF, Remigio LK: Histamine in nasal secretions and serum may be elevated during viral respiratory tract infections, Int Arch Allergy Appl Immunol 1982:67:380-383.
41. Pipkom U, Karlsson G, Enerback L: The cellular response of the human allergic mucosa to natural allergen exposure, J Allergy Clin Immunol 1988;82:1046-1054.
42. Abe Y, Ogino S, Irifunc M, Imamura I, Fukui H, Wada H, Matsunaga T: Histamine content, synthesis and degradation in human nasal mucosa, Clin Exp Allergy 1993:23:132-136.
43. Okayama M, Yamauchi K, Sekizawa K, Okayama H, Sasaki H, Inamura N, Maeyama K, Wata-nabe T, Takishima T, Shirato K: Localization of histamine N-methyltransferase messenger RNA in human nasal mucosa, J Allergy Clin Immunol 1995:95:96-102.
44. Corrado OJ, Gould CA, Kassab JY, Davies RJ: Nasal response of rhinitic and non-rhinitic subjects to histamine and mcthacholinc: A comparative study, Thorax 1986:41:863-868.
45. Raphael GD, Meredith SD, Baraniuk JN, Drucc HM, Banks SM, Kaliner MA: The pathophysiology ofrhinitis, II, Assessment of the sources of protein in histamine-induced nasal secretions, Am Rev Respir Dis 1989;139:791-800.
46. Mullol J, Raphael GD, Lundgren JD, Baraniuk IN, Merida M, Shelhamer JH, Kaliner MA: Comparison of human nasal mucosal secretion in vivo and in vitro, J Allergy Clin Immunol 1992:89:584-592.
47. Doyle WJ, Boehm S, Skoncr DP: Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy, J Allergy Clin Immunol 1990:86:924-935.
48. Okuda M, Watasc T, Mezawa A, Liu CM: The role of leukotriene D4 in allergic rhinitis, Ann Allergy 1988:60:537-540.
49. Bisgaard H, Olsson P, Bende M: Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humans, Clin Allergy 1986:16:289-297.
50. Miadonna A, Tedcschi A, Amoux B, Sala A, Zanussi C, Bcnvcniste J: Evidence of PAF-acethcr metabolic pathway activation in antigen challenge of upper respiratory airways, Am Rev Respir Dis 1989;140:142-147.
51. Shin MH, Avcrill FJ, Hubbard WC, Chilton FII, Baroody FM, Liu MC, Naclerio RM: Nasal allergen challenge generates 1 -0-hexadecy 1-2-Iy-so-sn-glycero-3-phosphocholine, Am J Respir Crit Care med 1994; 149:660-666.
52. Touqui L, Herpin-Richard N, Gene RM, Jullian E, Aljabi D, Hamberger C, Vargaftig BB, Des-sange JF: Excretion of platelet activating factor-acetylhydrolase and phospholipase A2 into nasal fluids after allergenic challenge: Possible role in the regulation of platelet activating factor release, J Allergy Clin Immunol 1994;94: 109-119.
53. Pipkom U, Karlsson G, Bake B: Effect of platelet activating factor on the human nasal mucosa, Allergy 1984:39:141-145.
54. Leggicri E, Tedcschi A, Lorini M, Bianco A, M iadonna A: Study of the effects of paf-acether on human nasal airways, Allergy 1991 ;46:466-471.
55. Ecclcs R: Plasma exudation in rhinitis, Clin Exp Allergy 1992;22:319-320.
56. Baumgarten CR, Togias AG, Naclerio RM, Lichtenstein LM, Norman PS, Proud D: Influx of kininogens into nasal secretions after antigen challenge of allergic individuals, J Clin Invest 1985:76:191-197.
57. Baumgarten CR, Nichols RC, Naclerio RM, Lichtenstein LM, Norman PS, Proud D: Plasma kallikrein during experimentally induced allergic rhinitis: Role in kinin formation and contribution to TAME-esterase activity in nasal secretions, J Immunol 1986:137:977-982.
58. Baumgarten CR, Nichols RC, Naclerio RM, Proud D: Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis, J Immunol 1986;137:1323-1328.
59. Proud D, Baumgarten CR, Naclerio RM, Ward PE: Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis. Immunol 1987:138:428-434.
60. Proud D, Togias A, Naclerio RM, Crush SA, Norman PS, Lichtenstein LM: Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen, J Clin Invest 1983:72:1678-1685.
61. Eccles R: Plasma exudation in rhinitis, Clin Exp Allergy 1992:22:319-320.
62. Andersson M, Michel L, Llull JB, Pipkom U: Complement activation on the nasal mucosal surface A feature of the immediate allergic reaction in the nose, Allergy 1994:49:242-245.
63. Proud D, Reynolds CJ, Lacapra S, Kagey-So-botka A, Lichtenstein LM, Naclerio RM: Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat, Am Rev Respir Dis 1988:137:613-616.
64. Rajakulasingam K, Polosa R, Lau LC, Church MK, Holgatc ST, Howarth PH: Nasal effects of bradykinin and capsaicin: Inlluencc on plasma protein leakage and role of sensory neurons, J Appl Physiol 1992:72:1418-1424.
65. Rajakulasingam K, Polosa R, Lau L.C, Church MK, Holgate ST, Howarth PH: Comparative nasal effects of bradykinin and histamine: Influence on nasal airways resistance and plasma protein exudation, Thorax 1993;48:324-329.
66. Braunstein G, Fajac I, Lacronique J, Frossard N: Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis, Am Rev Respir Dis 1991;144:630-635.
67. Canonica G, Ciprandi G: Adhesion molecules of the allergic inflammation: Recent insight on their functional role, Allergy 1994;49:135-141.
68. Campbell A, Vignola A, Chantez P, Godard P, Bousquet J: Low-alTinity receptor for IgE on human bronchial epithelial cells in asthma, Immunology 1994:82:506-508.
69. Vignola A, Crampette L, Mondain M, Sauvaire G, Czarlcwski Wj Bousquet J, Campbell A: Inhibitory activity of loratadinc and dcscarbocth-oxyloratadine on histamine activation of nasal epithelial cells, Allergy 1995:50:200-203.
70. Altman LC, Ayars GH, Baker C, Luchtel DL.: Cytokines and eosinophil-derived cationic proteins upregulate intercellular adhesion molecule- 1 on human nasal epithelial cells, J Allergy Clin Immunol 1993;92:527-536.
71. Mosimann BL, White MV, Hohman RJ, Gold-rich MS, Kaulbach HC, Kaliner MA: Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients, J Allergy Clin Immunol 1993;92:95-104.
72. Masini E, Rucci L, Cirri-Borghi MB, Giannclla E, Mannaioni PF: Stimulation and resection of vidian nerve in patients with chronic hypertrophic non-allergic rhinitis: Effect on histamine content in nasal mucosa, Agents Actions 1986;18:251-253.
73. Uddman R, Angaard A, Widdicotnbe J: Nerves and neurotransmitters in the nose; in Mygind N, Pipkom U (eds): Allergic and Vasomotor Rhinitis: Physiopathological Aspects, Copenhagen, Munksgaard, 1987, pp 50-65.
74. Freeland HS, Pipkom U, Schleimer RP, Bascom R, Lichtenstein LM, Naclerio RM, Peters SP: Leukotriene B4 as a mediator of early and late reactions to antigen in humans: The effect of systemic glucocorticoid treatment in vivo, J Allergy Clin Immunol 1989;83:634-642.
75. Klementsson H, Andersson M: Eosinophil cltc-motactic activity of topical PAF on the human nasal mucosa, Eur J Clin Pharmacol 1992:42: 295-299.
76. Okamoto Y, Shirotori K, Kudo K, Ishikawa K, Ito E, Togawa K, Saito I: Cytokine expression after the topical administration of substance P to human nasal mucosa, The role of substance P in nasal allergy, J Immunol 1993:151:4391-4398.
77. Tedeschi A, Milazzo N, Miadonna A: Nasal eo-sinophilia induced by PAF-acethcr is accompanied by the release of eosinophil cationic protein, Eur Respir J 1994:7:1445-1451.
78. Tedeschi A, Palumbo G, Milazzo N, Miadonna A: Nasal neutrophilia and eosinophilia induced by challenge with platelet activating factor, J Allergy Clin Immunol 1994;93:526-533.
79. Pclikan Z, Pelikan-Filipek M: Cytologic changes in the nasal secretions during the immediate nasal response, J Allergy Clin Immunol 1988: 82:1103-1112.
80. Naclerio RM, Proud D, Togias AG, Adkinson N Jr., Meyers DA, Kagey-Sobotka A, Plaut M, Norman PS, Lichtenstein LM: Inflammatory mediators in late antigen-induced rhinitis, N Engl J Med 1985;313:65-70.
81. lliopoulos O, Proud D, Adkinson N Jr., Norman PS, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM: Relationship between the early, late, and rcchallenge reaction to nasal challenge with antigen: Observations on the role of inflammatory mediators and cells, J Allergy Clin Immu-nol 1990;86:851-861.
82. Klementsson H: Eosinophils and the pathophysiology of allergic rhinitis, Clin Exp Allergy 1992:22:1058-1064.
83. Bascom R, Pipkom U, Lichtenstein LM, Naclerio RM: The influx of inflammatory cells into nasal w ashings during the late response to antigen challenge, Effect of systemic steroid pretreatment, Am Rev Respir Dis 1988:138:406-412.
84. Bascom R, Pipkom U, Proud D, Dunnette S, Gleich GJ, Lichtenstein LM, Naclerio RM: Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: Effect of systemic corticosteroids and relationship to eosinophil influx, .J Allergy Clin Immunol 1989:84:338-346.
85. Bascom R, Wachs M, Naclerio RM, Pipkom U, Galli SJ, Lichtenstein LM: Basophil influx occurs after nasal challenge: Effects of topical corticosteroid pretreatmem, J Allergy Clin Immunol 1988:81:580-589.
86. lliopoulos O, Baroody FM, Naclerio RM, Bochncr BS, Kagey-Sobotka A, Lichtenstein LM: Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils, J Immunol 1992:148:2223-2228.
87. Varney VA, Jacobson MR, Sudderick RM, Robinson DS, Irani AM, Schwartz LB, Mackay IS, Kay AB, Durham SR: Immunohistology of the nasal mucosa follwong allergen-induced rhinitis, Identification of activated T lymphocytes, eosinophils, and neutrophils, Am Rev Respir Dis 1992:146:170-176.
88. Juliusson S, Bachert C, Klementsson H, Karls-son G, Pipkorn U: Macrophages on the nasal mucosal surface in provoked and naturally occurring allergic rhinitis, Acta Otolaryngol (Stockh) 1991 ;U 1:946-953.
89. Pelikan Z, Pelikan-Filipek M: Cytologic changes in the nasal secretions during the late nasal response, J Allergy Clin Immunol 1989:83: 1068-1079.
90. Linder A, Venge P, Deuschl H: Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis, Allergy 1987:42:583-590.
91. Pastorello F.A, Riario-Sforza GG, Incorvaia C, Scgala M, Fumagalli M, Gandini R: Comparison of rhinomanometry, symptom score, and inflammatory cell counts in assessing the nasal late-phase reaction to allergen challenge, J Allergy Clin Immunol 1994:93:85- 92.
92. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, Kay AB, Hamid QA: Cytokine messenger RNA expression for IL-3, IL-4, 1L-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia, J Immunol 1992:148:2390- 2394.
93. Tcrada N, Konno A, Fukuda S, Yamashila T, Shirotori K, Okamoto Y, Ishikawa K, Togawa K: lrtcrleukin-5 gene expression in nasal mucosa and changes in amount of interleukin-5 in nasal lavage fluid after antigen challenge, Acta Otolaryngol (Stockh) 1994;114:203-208.
94. Ying S, Durham SR, Barkans J, Masuyama K, Jacobson M, Rak S, Lowhagcn O, Moqbcl R, Kay AB, Hamid QA: T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis, Am J Respir Cell Mol Biol 1993; 9:356-360.
95. Bradding P, Feather III, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JP, Hunt TC, Okayama Y, Heusser CH, et al: Interleukin 4 is localized to and released by human mast cells, J Exp med 1992;176:1381-1386.
96. Alant R, Sim TC, Hilsmeier K, Grant JA: Development of a new technique for recovery of cytokines from inflammatory sites in situ, J Immunol Methods 1992;155:25-29.
97. Sim TC, Grant JA, Hilsmeier KA, Fukuda Y, Alant R: Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge, Am J Respir Crit Care tried 1994; 149:339-344.
98. Gosset P, Malaquin F, Delneste Y, Wallaert B, C'apron A, Joseph M, Tonncl AB: lntcrleukin-6 and interleukin-1 alpha production is associated with antigen-induced late nasal response, J Allergy Clin Immunol 1993:92:878-890.
99. Terada N, Konno A, Tada H, Shirotori K, Ishikawa K, Togawa K: The effect of recombinant human interleukin-5 on eosinophil accumulation and degranulation in human nasal mucosa, J Allergy Clin Immunol 1992;90:160-168.
100. Bochncr B, Schleimer R: The role of adhesion molecules in human eosinophil and basophil recruitment, .J Allergy Clin Immunol 1994:94: 427-439.
101. Bochncr BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP: IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells, J Immunol 1995:154:799-803.
102. Alant R, Stafford S, Forsythe P, Harrison R, Faubion D, Lett-Brown MA, Grant JA: RANTF.S is a chemotactic and activating factor for human eosinophils, J Immunol 1993; 150:3442-3448.
103. Baggiolini M, Dahinden CA: CC chcmokincs in allergic inflammation, Immunol Today 1994:15:127-133.
104. Lee BJ, Naclerio RM, Bochner BS, Taylor RM, Lim MC, Baroody FM: Nasal challenge with allergen uprcgulales the local expression of vascular endothelial adhesion molecules, J Allergy Clin Immunol 1994:94:1006-1016.
105. Ciprandi G, Pronzato C, Ricca V, Passalacqua G, Bagnasco M, Canonica GW: Allergen-specific challenge induces intercellular adhesion molecule I (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects, Relationships with early and late inflammatory phenomena, Am J Respir Crit Care Med 1994; 150:1653—1659.
106. Haslctt C, Savill JS, Whyte MK, Stem M, Dransficld I, Meagher LC: Granulocyte apop-tosis and the control of inflammation, Philos Trans R Soc Lond Biol 1994;345:327-333.
107. Shimizu Y, Shaw S: Lymphocyte interactions with extracellular matrix, FASEB J 1991 ;5: 2292-2299.
108. Simon HU, Blaser K: Inhibition of programmed eosinophil death: A key pathogenic event for eosinophilia? Immunol Today 1995; 16:53-55.
109. Ohtoshi T, Tsuda T, Vanecheri C, Abrams JS, Gauldie J, Dolovich J, Denburg JA, Jordana M: Human upper airway epithelial cell-derived granulocyte-macrophage colony-stimulating factor induces histamine-containing cell differentiation of human progenitor cells, Int Arch Allergy Appl Immunol 1991:95:376-384.
110. Xing Z, Ohtoshi T, Ralph P, Gauldie J, Jordana M: Human upper airway structural cell-derived cytokines support human peripheral blood monocyte survival: A potential mechanism for monocyte/macrophage accumulation in the tissue, Am J Respir Cell Mol Biol 1992; 6:212-281.
111. Gerth-van-Wijk R: Nasal hyperreactivity: Its pathogenesis and clinical significance, Clin Exp Allergy 1991:21:661-667.
112. Klemcntsson H, Andersson M, Pipkorn U: Allergen-induced increase in nonspecific nasal reactivity is blocked by antihistamines without a clear-cut relationship to eosinophil influx, J Allergy Clin Immunol 1990;86:466-472.
113. Klementsson II, Andersson M, Baumgarten CR, Venge P, Pipkorn U: Changes in non-specific nasal reactivity and eosinophil influx and activation after allergen challenge, Clin Exp Allergy 1990;20:539-547.
114. Connell J: Quantitative intranasal pollen challenges, II, Effect of daily pollen challenge, environmental pollen exposure and placebo challenge on the nasal membrane, J Allergy 1968: 41:123-129.
115. Wachs M, Proud D, Lichtenstein LM, Kagcy-Sobotka A, Norman PS, Naclerio RM: Observations on the pathogenesis of nasal priming, J Allergy Clin Immunol 1989;84:492-501.
116. Grant JA, Alam R, Lett-Brown MA: Histamine-releasing factors and inhibitors: Historical perspectives and possible implications in human illness, J Allergy Clin Immunol 1991; 88:683-693.
117. Takafuji S, Bischoff SC, De-Week AL, Dahin-den CA: Opposing effects of tumor necrosis factor-alpha and nerve growth factor upon leukotriene C4 production by human eosinophils triggered with N-formyl-methonyl-leucyl-phenylalaninc, Eur J Immunol 1992:22:969-974.
118. Sim TC, Alam R, Forsythe PA, Welter JB, Lett-Brown MA, Grant JA: Measurement of histamine-releasing factor activity in individual nasal washings: Relationship with atopy, basophil response, and membrane-bound IgF., J Allergy Clin Immunol 1992:89:1157-1165.
119. Sim TC, Hilsmcier KA, Alam R, Allen RK, Lett-Brown MA, Grant JA: Effect of topical corticosteroids on the recovery of histamine releasing factors in nasal washings of patients with allergic rhinitis, A double-blind, randomized, placebo-controlled study, Am Rev Respir Dis 1992:145:1316-1320.
120. Bousquet J, Hcjjaoui A, Becker WM, Cour P, Chanal I, Lebel B, Dhivert H, Michel FB: Clinical and immunologic reactivity of patients allergic to grass pollens and to multiple pollen species, I, Clinical and immunologic characteristics, J Allergy Clin Immunol 1991 ;87: 737-746.
121. Juliusson S, Pipkom U, Karlsson G, Enerback L: Mast cells and eosinophils in the allergic mucosal response to allergen challenge: Changes in distribution and signs of activation in relation to symptoms, J Allergy Clin Immunol 1992:90:898-909.
122. Hakansson L, Rak S, Dahl R, Venge P: The formation of eosinophil and neutrophil chemo-tactic activity during a pollen season and after allergen challenge, J Allergy Clin Immunol 1989;83:933-939.
123. Andersson M, Svensson C, Andersson P, Pipkom U: Objective monitoring of the allergic inflammatory response of the nasal mucosa in patients with hay fever during natural allergen exposure, Am Rev Respir Dis 1989:139:91l-914.
124. Igarashi Y, Skoncr DP, Doyle WJ, White MV, Fireman P, Kaliner MA: Analysis of nasal secretions during experimental rhinovirus upper respiratory infections, J Allergy Clin Immunol 1993:92:722- 731.
125. Enerback L, Pipkorn U, Olofsson A: Intrae-pithelial migration of mucosal mast cells in hay fever: Ultrastructural observations, Int Arch Allergy Appl Immunol 1986:81:289-297.
126. Otsuka H, Denburg J, Dolovich J, Hitch D, Lapp P, Rajan RS, Bienenstock J, Befus D: Heterogeneity of metachromatic cells in human nose: Significance of mucosal mast cells, J Allergy Clin Immunol 1985:76:695-702.
127. Viegas M, Gomez E, Brooks J, Gatland D, Davies RJ: Effect of the pollen season on nasal mast cells, Br Med J 1987:294:414.
128. Gomez E, Clague JE, Gatland D, Davies RJ: Effect of topical corticosteroids on seasonally induced increases in nasal mast cells, Br Med J 1988:296:1572-1573.
129. Fokkens WJ, Broekhuis-Fluitsma DM, Rijntjcs E, Vroom TM, Hoefsmit EC: Langer-hans cells in nasal mucosa of patients w ith grass pollen allergy, Immunobiology 1991; 182:135-142.
130. Skoner DP, Lee L., Doyle WJ, Boehm S, Fireman P: Nasal physiology inflammatory mediators during natural pollen exposure, Ann Allergy 1990;65:206-210.
131. Rasp G, Thomas PA, Bujia J: Eosinophil inflammation of the nasal mucosa in allergic and non-allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serum, Clin Exp Allergy 1994:24:1151- 1156.
132. Linder A, Strandberg K, Deuschl H: Histamine concentrations in nasal secretion and secretory activity in allergic rhinitis, Allergy 1987;42:126-134.
133. Wang D, Clement P, Smitz J, De-Waele M, Derde MP: Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure, Int Arch Allergy Immunol 1995:106: 278-285.
134. Lim MC, Taylor RM, Naclerio RM: The histology of allergic rhinitis and its comparison to cellular changes in nasal lavage, Am J Respir Crit Care Med 1995:151:136-144.
135. Ciprandi G, Pronzato C, Ricca V, Bagnasco M, Canonica GW: Evidence of intercellular adhesion molecule-1 expression on nasal epithelial cells in acute rhinoconjunctivitis caused by pollen exposure, J Allergy Clin Immunol 1994;94:738-746.
136. Greiff L, Wollmer P, Svensson C, Andersson M, Persson CG: Effect of seasonal allergic rhinitis on airway mucosal absorption of chromium-51 labelled EDTA, Thorax 1993:48: 648-650.
137. Persson CG, Erjcfalt I, Alkner U, Baumgarten C, Greiff L, Gustafsson B, Luts A, Pipkom U, Sundler F, Svensson C, et al: Plasma exudation as a first line respiratory mucosal defence, Clin Exp Allergy 1991:21:17-24.
138. Chaen T, Watanabe N, Mogi G, Mori K, Take-yama M: Substance P and vasoactive intestinal peptide in nasal secretions and plasma from patients with nasal allergy, Ann Otol Rhinol Laryngol 1993;102:16-21.
139. Van Megen YJ, Klaasscn AB, Rodrigues-de-Miranda JF, van Ginnekcn CA, Wcntges BT: Alterations of adrenoceptors in the nasal mucosa of allergic patients in comparison with nonallergic individuals, J Allergy Clin Immunol 1991;87:530-540.
140. Var Megen YJ, Klaassen AB, Rodrigues-de-Miranda JF, van Ginnekcn CA, Wentges BT: Alterations of muscarinic acetylcholine receptors in the nasal mucosa of allergic patients in comparison with nonallergic individuals, J Allergy Clin Immunol 1991;87:521-529.
141. White MV: Nasal cholinergic hyperresponsiveness in atopic subjects studied out of season, J Allergy Clin Immunol 1993;92:278—287.
142. Jacobs RL, Freedman PM, Boswell RN: Non-allcrgic rhinitis with eosinophilia (NARHS syndrome), Clinical and immunologic presentation, J Allergy Clin Immunol 1981:67: 253-262.
143. Anggard A: Vasomotor rhinitis Pathophysiological aspects, Rhinology 1979:17:31-35.
144. Malmbcrg H, Middleton E, Holopaincn E, Withl J: Eosinophilia; in Mygind N, Wceke B (eds): Allergic and Vasomotor Rhinitis: Clinical Aspects, Copenhagen, Munksgaard, 1986, p 91.
145. Knani J, Campbell A, Enandcr I, Peterson CG, Michel FB, Bousquet J: Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis, J Allergy Clin Immunol 1992;90: 880-889.
146. Malmberg H: Symptoms of chronic and allergic rhinitis and occurrence of nasal secretion granulocytes in university students, school children and infants, Allergy 1979:34:389-394.
147. Mullarkey MF, Hill JS, Webb DR: Allergic and nonallergic rhinitis: Their characterization with attention to the meaning of nasal eosinophilia, J Allergy Clin Immunol 1980:65:122-126.
148. Spector SL, English G, Jones L: Clinical and nasal biopsy response to treatment of perennial rhinitis, J Allergy Clin Immunol 1980:66:129—137.
149. Garrclds I, DcGraffintVeld T, Nahori M, Vargaftig B, VanWijk R, Zilstra F, Interleukin-5 and eosinophil cationic protein in nasal lavages of rhinitis patients, Eur J Pharmacol 1995;275:295-300.
150. Wilson J, Reilly K, Salter D, Yap PL, Dawes J, Bametson R, Murray J, Maran A: Nasal histamine and heparin in chronic rhinitis, Ann Otol Rhinol Laryngol 1988:97:389- 392.
151. Montcfort S, Feather IH, Wilson SJ, Haskard DO, Lee TH, Holgate ST, Howarth PH: The expression of leukocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis, Am J Respir Cell Mol Biol 1992;7: 393-398.
152. Saito H, Asakura K, Kataura A: Study on the IL-5 expression in allergic nasal mucosa, Int Arch Allergy Immunol 1994;104:39-40.
153. Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, Howarth PH: Immu-nolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects, The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation, J Immunol 1993;151:3853-3865.
154. Kowalski ML, Gregorczyk J, Sliwinska-Ko-walska M, Wojciechowska B, Rozniecka M, Rozniecki J: Neutrophil chemotactic activity (NCA) in nasal secretions from atopic and nonatopic subjects, Effect of antigen challenge, Allergy 1993;48:409-414.
155. Calderon-Garciduenas L, Osorno-Velazquez A, Bravo-Alvarez H, Delgado-Chavez R, Bar-rious-Marquez R: Histopathologic changes of the nasal mucosa in southwest metropolitan Mexico City inhabitants, Am J Pathol 1992; 140:225-232.
156. Koltai PJ: Effects of air pollution on the upper respiratory tract of children, Otolaryngol Head NeckSurg 1994;111:9-11.
157. McBride DE, Koenig JQ, Luchtel DL, Williams PV, Henderson W Jr.: Inflammatory effects of ozone in the upper airways of subjects with asthma, Am J Respir Crit Care Med 1994: 149:1192-1197.
158. Frischer TM, Kuehr J, Pullwitt A, Meinert R, Forster J, Studnicka M, Koren H: Ambient ozone causes upper airways inflammation in children, Am Rev Respir Dis 1993; 148:961- 964.
159. Willes SR, Fitzgerald TK, Bascom R: Nasal inhalation challenge studies with sidestream tobacco smoke, Arch Environ Health 1992;47: 223-230.
160. Afzclius BA: Ultrastructure of human nasal epithelium during an episode of eoronavirus infection, Virchows Arch 1994;424:295-300.
161. Proud D, Gwaltney J Jr., Hcndlcy JO, Dinarello CA, Gillis S, Schleimer RP: Increased levels of interleukin-1 arc detected in nasal secretions of volunteers during experimental rhinovirus colds, J Infect Dis 1994:169:1007-1013.
162. Linden M, Greiff L, Andersson M, Svcnsson C, Akerlund A, Bende M, Andersson E, Pers-son C: Nasal cytokines in common cold and allergic rhinitis, Clin Exp Allergy 1995:25: 166-172.
163. Proud D, Bailey GS, Naclerio RM, Reynolds CJ, Cruz AA, Eggleston PA, Lichtenstein LM, Togias AG: Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions, J Allergy Clin Immunol 1992:89:1098-1110.
164. Togias AG, Naclerio RM, Proud D, Fish JE, Adkinson N Jr., Kagey-Sobotka A, Norman PS, Lichtenstein LM: Nasal challenge with cold, dry air results in release of inflammatory mediators, Possible mast cell involvement, J Clin Invest 1985;76:1375-1381.
165. llliopoulos O, Proud D, Norman PS, Lichtenstein LM, Kagey-Sobotka A, Naclerio RM: Nasal challenge with cold, dry air induces a late-phase reaction, Am Rev Respir Dis 1988: 138:400-405.